/Companies

Torpedo Therapeutics

YC W22

Boston, US · Founded 2018 · 5 employees · 3 known investors

Find your way into Torpedo Therapeutics

Sign up to see every warm intro you have to Torpedo Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Torpedo Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Torpedo Therapeutics develops high-precision, closed-loop deep brain stimulation devices for treating neurological disorders including Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy. The company uses micro- and nano-fabrication to create ultra-small electrode leads with machine learning-driven parameter adjustment to reduce side effects and improve treatment efficacy.

Also known as Neural Dynamics · Neural Dynamics Technologies · Neural Dynamics Technologies Inc. · Neural Dynamics Technologies LLC · Neural Dynamics Technologies LLC, Neural Dynamics, Neural Dynamics Technologies, Neural Dynamics Technologies Inc.

Founders & leadership· Y Combinator alumni (W22)

Torpedo Therapeutics was founded in 2018 by Ingrid van Welie.

IVIngrid van Welie
Ingrid van WelieFounder and CEOIngrid van Welie holds a PhD and founded Torpedo Therapeutics, where she serves as CEO. Her background is in neuroscience and biophysics, with focus on technologies for measuring and modulating neuronal electrical activity.

Investors · 3

Related companies · 5

Companies working in the same space as Torpedo Therapeutics.

Legal entities · 1

corporate structure
Neural Dynamics Technologies Inc.

Frequently asked questions

What does Torpedo Therapeutics do?
Torpedo Therapeutics develops high-precision, closed-loop deep brain stimulation devices for treating neurological disorders including Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy. The company uses micro- and nano-fabrication to create ultra-small electrode leads with machine learning-driven parameter adjustment to reduce side effects and improve treatment efficacy.
Who founded Torpedo Therapeutics?
Torpedo Therapeutics was founded by Ingrid van Welie in 2018.
Who are Torpedo Therapeutics's investors?
Torpedo Therapeutics's investors include Y Combinator, Black Mountain Investment Group, Coho Deeptech.
Where is Torpedo Therapeutics headquartered?
Torpedo Therapeutics is headquartered in Boston, US.